UPSA Médica NV SA in Consumer Health (Belgium)

  • ID: 2878411
  • Company Profile
  • Region: Belgium
  • 2 pages
  • Euromonitor International
1 of 3
The main challenge for UPSA Médica, the leading company in consumer health, will be the growing aggressiveness of generics. Belgians previously used to ask for a box of Dafalgan but are increasingly simply requesting a pack of acetaminophen, thus showing that the acetaminophen category is becoming more generic. UPSA Médica should have reacted with new variants of Dafalgan, but nothing happened until the end of 2014.

These Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Consumer Health market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 3
UPSA MÉDICA NV SA IN CONSUMER HEALTH (BELGIUM)

November 2015

LIST OF CONTENTS AND TABLES

Strategic Direction
Key Facts
Summary 1 UPSA Médica NV SA: Key Facts
Summary 2 UPSA Médica NV SA: Operational Indicators
Competitive Positioning
Summary 3 UPSA Médica NV SA: Competitive Position 2015
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll